Key result
Radical stop-codon mutations linked to ~16-year earlier onset of ARVC/D vs missense mutations.
Why the study?
Age-dependent clinical and genetic differences in ARVC/D remain unknown despite known mean age at onset or diagnosis around the 30-40s.
Observational (n=35)
Absolute Event Rate: 29.4% vs 45.8%
p-value: p=0.0266
In Japanese patients with ARVC/D, initial presentation with cardiopulmonary arrest and the presence of PKP2 premature stop codon mutations are associated with a significantly younger age of disease onset.
May inform earlier family screening for radical PKP2 mutations; leaves open prospective validation of genotype-guided risk stratification.
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a heart muscle disease caused by desmosomal gene mutations, and presents as ventricular tachycardia and sudden cardiac death. Although the mean age at onset or diagnosis of ARVC/D are reported to be around the 30-40s, the age-dependent clinical and genetic differences remain unknown. METHODS AND RESULTS: A total of 35 consecutive Japanese probands (23 male) who were clinically diagnosed with ARVC/D were enrolled in the present study, and genetic analysis of PKP2, DSP, DSG2, and DSC2 was done. The mean age at the first symptom and at diagnosis was 38.6±14.8 years and 40.5±17.7 years, respectively. Probands in whom the onset was cardiopulmonary arrest were significantly younger (22.3±15.3 years) than those with arrhythmia (41.1±13.2 years) or congestive heart failure (45.7±8.5 years). On genetic screening, 19 mutation carriers were identified. Although there was no age dependence for each gene mutation carrier, carriers with PKP2 premature stop codon developed the disease at a significantly younger age than other mutation carriers. CONCLUSIONS: The initial clinical manifestations in some young probands were very severe, and PKP2 mutations with a premature stop codon would be associated with disease onset at a younger age.
No takes yet. Share an insight, caveat, or question.
Ohno et al. (2013) conducted an observational in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) (n=35). Radical mutations (premature stop codon) vs. Missense mutations was evaluated on Age at disease onset (p=0.0266). Patients with ARVC/D carrying radical mutations with a premature stop codon developed the disease at a significantly younger age (29.4 years) compared to those with missense mutations (45.8 years).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: